Capturing an elusive but critical element: Natural protein enables actinium chemistry.

Deblonde, Gauthier J-P; Mattocks, Joseph A; Dong, Ziye; Wooddy, Paul T; Cotruvo, Joseph A; Zavarin, Mavrik · Sci Adv · 2021

basic_science · Level V

Where this comes from

Abstract

Actinium-based therapies could revolutionize cancer medicine but remain tantalizing due to the difficulties in studying and limited knowledge of Ac chemistry. Current efforts focus on small synthetic chelators, limiting radioisotope complexation and purification efficiencies. Here, we demonstrate a straightforward strategy to purify medically relevant radiometals, actinium(III) and yttrium(III), and probe their chemistry, using the recently discovered protein, lanmodulin. The stoichiometry, solution behavior, and formation constant of the <sup>228</sup>Ac<sup>3+</sup>-lanmodulin complex and its <sup>90</sup>Y<sup>3+</sup>/<sup>nat</sup>Y<sup>3+</sup>/<sup>nat</sup>La<sup>3+</sup> analogs were experimentally determined, representing the first actinium-protein and strongest actinide(III)-protein complex (sub-picomolar <i>K</i><sub>d</sub>) to be characterized. Lanmodulin’s unparalleled properties enable the facile purification recovery of radiometals, even in the presence of >10<sup>+10</sup> equivalents of competing ions and at ultratrace levels: down to 2 femtograms <sup>90</sup>Y<sup>3+</sup> and 40 attograms <sup>228</sup>Ac<sup>3+</sup>. The lanmodulin-based approach charts a new course to study elusive isotopes and develop versatile chelating platforms for medical radiometals, both for high-value separations and potential in vivo applications.